Cargando…

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

In Navarre, Spain, in May 2022, the seroprevalence of anti-nucleocapsid (N) and anti-spike (S) antibodies of SARS-CoV-2 was 58.9% and 92.7%, respectively. The incidence of confirmed COVID-19 thereafter through July was lower in people with anti-N antibodies (adjusted odds ratio (aOR) = 0.08; 95% con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castilla, Jesús, Lecea, Óscar, Martín Salas, Carmen, Quílez, Delia, Miqueleiz, Ana, Trobajo-Sanmartín, Camino, Navascués, Ana, Martínez-Baz, Iván, Casado, Itziar, Burgui, Cristina, Egüés, Nerea, Ezpeleta, Guillermo, Ezpeleta, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389855/ https://www.ncbi.nlm.nih.gov/pubmed/35983774 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.33.2200619

Ejemplares similares

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2021)

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018)

Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study
por: Fresán, Ujué, et al.
Publicado: (2021)

Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
por: Castilla, Jesús, et al.
Publicado: (2017)

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers
por: Martínez-Baz, Iván, et al.
Publicado: (2020)

Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2021)

Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2021)

Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons
por: Casado, Itziar, et al.
Publicado: (2014)

Effect of influenza vaccination in patients with asthma
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Detection of Respiratory Viruses in Deceased Persons, Spain, 2017
por: Navascués, Ana, et al.
Publicado: (2018)

Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022
por: Casado, Itziar, et al.
Publicado: (2023)

Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16
por: Castilla, Jesús, et al.
Publicado: (2018)

Use of Medical Care during Pandemic (H1N1) 2009, Navarre, Spain
por: Burgui, Rosana, et al.
Publicado: (2011)

Design and validation of a multiplex PCR protocol for microsatellite typing of Candida parapsilosis sensu stricto isolates
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2018)

Temporal evolution of brain cancer incidence in the municipalities of Navarre and the Basque Country, Spain
por: Ugarte, María Dolores, et al.
Publicado: (2015)

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021)

Primera onda pandémica de COVID-19 en Navarra, febrero-junio 2020
por: Castilla, J., et al.
Publicado: (2022)

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
por: Kissling, Esther, et al.
Publicado: (2021)

Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain
por: Juanbeltz, Regina, et al.
Publicado: (2018)

Mycoplasma pneumoniae y resistencias a macrólidos: ¿Conocemos la situación en Europa?
por: Varela, Ana Isabel Álvaro, et al.
Publicado: (2023)

Artritis meningocócica primaria
por: Machain, Estibaliz Erviti, et al.
Publicado: (2021)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Brain and Central Nervous System Cancer Incidence in Navarre (Spain), 1973-2008 and Projections for 2014
por: Etxeberria, J., et al.
Publicado: (2015)

Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
por: Adelantado, Marta, et al.
Publicado: (2019)

Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain
por: Castilla, Jesús, et al.
Publicado: (2021)

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2015)

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study
por: Martínez-Baz, Iván, et al.
Publicado: (2013)

Seroprevalence and socioeconomic impact of the first SARS-CoV-2 infection wave in a small town in Navarre, Spain
por: Ribes, Marta, et al.
Publicado: (2023)

Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013
por: Godoy, Pere, et al.
Publicado: (2016)

Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012–2013
por: Alvarez, Josep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4jknjb73ikq1ppij5etlpfb0rv